Successful long-term enzyme replacement therapy in a young adult with Fabry disease

被引：6
|
作者：
Kampmann, C. [1 ]
Kalkum, G. [1 ]
Beck, M. [1 ]
Whybra, C. [1 ]
机构：
[1] Univ Med Ctr Mainz, Ctr Dis Childhood & Adolescence, Sect Lysosomal Storage Dis & Cardiol, Mainz, Germany
来源：
CLINICAL GENETICS | 2013年 / 83卷 / 04期
关键词：
D O I：
10.1111/j.1399-0004.2012.01916.x
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：395 / 396
页数：2
相关论文
共 50 条
  • [21] Individualization of long-term enzyme replacement therapy for Gaucher disease
    Andersson, HC
    Charrow, J
    Kaplan, P
    Mistry, P
    Pastores, GM
    Prakesh-Cheng, A
    Rosenbloom, BE
    Scott, CR
    Wappner, RS
    Weinreb, NJ
    GENETICS IN MEDICINE, 2005, 7 (02) : 105 - 110
  • [22] Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
    Saskia M Rombach
    Bouwien E Smid
    Machtelt G Bouwman
    Gabor E Linthorst
    Marcel G W Dijkgraaf
    Carla E M Hollak
    Orphanet Journal of Rare Diseases, 8
  • [23] Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
    Rombach, Saskia M.
    Smid, Bouwien E.
    Bouwman, Machtelt G.
    Linthorst, Gabor E.
    Dijkgraaf, Marcel G. W.
    Hollak, Carla E. M.
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [24] Long term enzyme replacement therapy for Fabry disease: effectiveness on heart, kidney and brain
    Cabrera, Gustavo H.
    Manuel Politei, Juan
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S33 - S33
  • [25] Long term clinical outcomes in patients with Fabry disease receiving enzyme replacement therapy
    McKechnie, Douglas G. J.
    Mac Lochlainn, Dylan J.
    Mehta, Atul B.
    Hughes, Derralynn A.
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S78 - S79
  • [26] Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
    Beck, Michael
    Hughes, Derralynn
    Kampmann, Christoph
    Larroque, Sylvain
    Mehta, Atul
    Pintos-Morell, Guillem
    Ramaswami, Uma
    West, Michael
    Wijatyk, Anna
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S19 - S20
  • [27] Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
    Beck, Michael
    Hughes, Derralynn
    Kampmann, Christoph
    Larroque, Sylvain
    Mehta, Atul
    Pintos-Morell, Guillem
    Ramaswami, Uma
    West, Michael
    Wijatyk, Anna
    Giugliani, Roberto
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 3 : 21 - 27
  • [28] Characteristics of the Electrocardiogram in Japanese Fabry Patients Under Long-Term Enzyme Replacement Therapy
    Morimoto, Satoshi
    Nojiri, Ayumi
    Fukuro, Eiko
    Anan, Ikuko
    Kawai, Makoto
    Sakurai, Ken
    Kobayashi, Masahisa
    Kobayashi, Hiroshi
    Ida, Hiroyuki
    Ohashi, Toya
    Shibata, Takahiro
    Yoshimura, Michihiro
    Eto, Yoshikatsu
    Hongo, Kenichi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 7
  • [29] Successful pregnancy in a patient with Fabry disease receiving enzyme replacement therapy
    Dehout, F
    Roland, D
    Henry, F
    Langlois, A
    Van Maldergem, L
    ACTA PAEDIATRICA, 2006, 95 : 137 - 138
  • [30] Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy
    Kovacevic-Preradovic, T.
    Zuber, M.
    Jost, C. H. Attenhofer
    Widmer, U.
    Seifert, B.
    Schulthess, G.
    Fischer, A.
    Jenni, R.
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2008, 9 (06): : 729 - 735
12345